Analyst Suji Desilva of Roth Capital maintained a Buy rating on D-Wave Quantum and raised the 12-month price target from $10 ...

Concerns over U.S. tariff policy changes drove a sharp pullback in Shopify stock earlier in the year. However, Toner noted ...

The announcement prompted ATB Capital Markets analyst Martin Toner to downgrade Docebo from “Outperform” to “Sector Perform” ...

Following the company’s most recent results, RBC Dominion Securities analyst James McGarragle is feeling more bullish about ...

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.

Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

Xtract One Technologies may be nearing a significant financial milestone, with Ventum Capital calling the security tech firm ...

Extendicare (Extendicare Stock Quote, Chart, News, Analysts, Financials TSXV:EXE) is expanding its home healthcare footprint with a $75.5-million acquisition, and analyst Douglas Loe says the ...

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

ATB Capital Markets analyst Martin Toner has to maintained his “Outperform” rating and $210.00 price target on KXS.

Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.